June 23, 2023 — Thomas Schatz
Pharmaceutical price controls in President Biden's budget and the SMART Choices Act will devastate drug development.
June 23, 2023 — Thomas Schatz 1687562641
April 26, 2023 — Christina Smith
Intellectual property rights must be protected to encourage future research and development of life saving cures.
April 26, 2023 — Christina Smith 1682526076
August 2, 2022 — Thomas Schatz
The Inflation Reduction Act of 2022 will raise taxes, increase spending, and prolong both inflation and the recession.
August 2, 2022 — Thomas Schatz 1659456312
CAGW Submits Comments on FTC's Interim Staff Report on PBMs
Overregulating PBMs will drive up prescription drug costs and be a disservice to the millions of patients that benefit from them.